Forbes April 8, 2024
The home “Test to Treat” program is closing April 16, leaving disabled and vulnerable Covid-19 patients without good options for accessing timely diagnosis and care.
While the Rapid Acceleration of Diagnostics Tech claims an intent to “reduce disparities for those underserved and vulnerable populations who are disproportionately affected by” Covid-19, dropping the program is an odd way of demonstrating this. The program allowed people to enroll and receive Pfizer’s COVID-19 & Flu Home Test. If they were symptomatic and had a positive test, they could receive free telehealth services.
When the program was announced as a pilot in Pennsylvania in January 2023 and then expanded nationally in December, no mention was made about how short-lived the program would be.
Andrew...
Today's Sponsors
Today's Sponsor